In this article, Dr. Norman Levine sums up his takeaways from the American Academy of Dermatology annual meeting, beginning with a presentation by two physicians who addressed the difficulties of managing hidradenitis suppurativa, such as fixed dosing. He also addressed controversies associated with treatments for atopic dermatitis. Apparently, bleach baths are no better than regular baths in improving skin symptoms.
It’s easy to become overwhelmed by all that we see in the world and the responsibilities of life. Yet there are plenty of ways to build your own resilience, improve your perspective and keep a spring in your step.
On International Women's Day, it's time to take stock on the state of gender equality.
Skin can act as a window to a patient’s general health says a physician writing in the journal Medicine. Changes may signal underlying disease from lupus to gastrointestinal disease.
Knowledge of outcomes data, adverse events may help physicians formulate effective treatment strategies, Dr. April Armstrong says.
Identifying associations with actinic keratosis variability instead of prevalence can be used to closely monitor organ transplant recipients at increased risk of developing actinic keratosis, researchers say.
Coordinated care is gaining ground in medicine because it helps defragment a fragmented system, says Dr. Lindsay Strowd. Patients with chronic conditions, such as psoriasis, tend to benefit most.
Physicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
Initial results of an investigator-initiated phase 4 trial suggest that blocking interleukin-12 (IL-12) and IL-23 may reduce cardiovascular inflammation associated with psoriasis, researchers reported at AAD 2018.
Diagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.
While the vast majority of basal cell carcinomas are treated and resolved with surgery, systemic therapy with one of the two hedgehog pathway inhibitors could be a treatment option for unresectable or metastasized disease, researchers reported at the American Academy of Dermatology annual meeting in San Diego this week.
Injectable aesthetic products recently FDA-approved or in late stages of development include polycaprolactone, a new hyaluronic acid and multiple neuromodulators.
The transgender dermatology patient may face a unique set of challenges doctors should be prepared to address, says Dr. Brian Ginsberg.
With one approved biologic available and many more under investigation, the future of treatment for hidradenitis suppurativa looks very promising.
Speaking at the American Academy of Dermatology annual meeting in February, Dr. Brett Coldiron described challenges dermatologists should be prepared for this year, including Medicare payment reductions, insurers' cost-saving strategies and practice consolidations.
This week during the annual meeting of the American Academy of Dermatology in San Diego, Robert Sidbury, M.D., addressed developments in atopic dermatitis treatments since the publication of treatment guidelines in 2014.
During the American Academy of Dermatology’s annual meeting, physicians addressed the monumental changes that have occurred since the advent of biologic therapy for systemic autoimmune conditions, such as psoriasis and atopic dermatitis. Today, some patients are able to achieve complete disease clearance. Although there may be viable treatments for these conditions, access to care and medication adherence remain top issues, physicians say.
Multidisciplinary skin cancer care is an approach that might not only improve patient outcomes, but also professional satisfaction, researchers reported at AAD 2018 this week in San Diego.
There's been much debate in the literature about the need for and role of vitamin D, which may encourage patients to overdo vitamin dosing, researchers said at AAD 2018 this week.
Female patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.
Dermatology Times will be reporting from the AAD annual meeting this week in San Diego. Visit our conference news page to follow the developments from the meeting.
Fear associated with perceived pain from injectable biologics has been shown to be successfully addressed by employing anchoring bias interventions, researchers report in JAMA Dermatology.
The microbiome is one of the most popular areas of skin research at present. Many dermatologic diseases are accompanied by abnormal microbiomes beginning with atopic dermatitis, says Dr. Zoe Diana Draelos in her monthly column, Cosmetic Conundrums.
Dermatologists recommend moisturizers for patients who suffer from atopic dermatitis, contact dermatitis and psoriasis. Some over-the-counter moisturizers contain allergens patients should avoid. For details, print our table-of-the-month.
In this issue of Dermatology Times, we feature pediatric dermatology research, beginning with advances in junctional epidermolysis bullosa that led to the development of new skin for one young patient.
Balancing a career or business, a family and a household is a given for many of us. When it comes to keeping cool and maintaining relationships with family, colleagues and our patients, communication and education are key. Here's how one tool can help.
Looking for how to build strong business relationships? Here's a checklist to help you connect more effectively with current and potential partners.
Pediatricians respond to the first successful gene therapy treatment for epidermolysis bullosa.
